Could a steroid cocktail save sepsis patients from organ failure?
NCT ID NCT04280497
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 27 times
Summary
This study tests whether a combination of two steroids (hydrocortisone and fludrocortisone) can reduce death or long-term organ damage in adults with sepsis in the ICU. About 1,800 participants will receive either the steroids or a placebo, and researchers will track survival and organ function for up to 6 months. The goal is to find out which sepsis patients benefit most from this treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of medical and surgical Intensive Care Unit, Raymond Poincaré Hospital - APHP
RECRUITINGGarches, Hauts-de-Seine, 92380, France
Conditions
Explore the condition pages connected to this study.